Supernus Pharmaceuticals (SUPN) Cash & Current Investments (2011 - 2026)
Supernus Pharmaceuticals' Cash & Current Investments came in at $372.07 million for Q2 2026, down 28.8% from $522.6 million a year earlier and down 3.2% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Cash & Current Investments (2011 - 2026) Analysis & Trends
At the end of FY2025, Supernus Pharmaceuticals' Cash & Current Investments was $308.67 million, down 32.0% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of -6.1% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $453.61 million in FY2024 (+78.0%), $254.87 million in FY2023 (-44.8%), $461.33 million in FY2022 (+35.8%) and $339.68 million in FY2021 (-19.6%).
- The five-year range for quarterly Cash & Current Investments is $151.66 million (Q2 2023) to $522.6 million (Q2 2025).
- Year-over-year, Cash & Current Investments has declined for four consecutive quarters, with growth averaging 22.2% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2024 (growth of 128.9%), and the weakest in Q2 2023 (a decline of 58.0%).
- Business Quant data shows SUPN's Cash & Current Investments at $384.24 million (Q1 2026), $308.67 million (Q4 2025) and $281.16 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn | 372.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 372.07 Mn |
| Mar 31, 2026 | 384.24 Mn |
| Dec 31, 2025 | 308.67 Mn |
| Sep 30, 2025 | 281.16 Mn |
| Jun 30, 2025 | 522.60 Mn |
| Mar 31, 2025 | 463.59 Mn |
| Dec 31, 2024 | 453.61 Mn |
| Sep 30, 2024 | 403.21 Mn |
| Jun 30, 2024 | 347.19 Mn |
| Mar 31, 2024 | 297.74 Mn |
| Dec 31, 2023 | 254.87 Mn |
| Sep 30, 2023 | 200.19 Mn |
| Jun 30, 2023 | 151.66 Mn |
| Mar 31, 2023 | 228.57 Mn |
| Dec 31, 2022 | 461.33 Mn |
| Sep 30, 2022 | 391.79 Mn |
| Jun 30, 2022 | 360.79 Mn |
| Mar 31, 2022 | 312.20 Mn |
| Dec 31, 2021 | 339.68 Mn |
| Sep 30, 2021 | 443.85 Mn |
API Access
Supernus Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();